The antiepileptic drug valproic acid (VPA) was also reported to improve cerebral ischemia/reperfusion injury via modulating an apoptosis repressor with caspase recruitment domain (ARC)-mediated caspase-1-dependent pyroptosis pathway (Zhu et al., 2019). The gene discussed is CASP1; the disease is Cerebral ischemia.